Japanese shares closed lower on Wednesday, impacted by a drop in automakers following U.S. President Trump's auto tariff ...

The new tariff plans of US President Donald Trump will lift near-term inflation and hurt growth in the medium term according to a report by Standard Chartered. Show Full Article The report says ...

Convergence between India and the United States on bilateral, regional and global issues is much greater than divergences on ...

In a joint televised interview with billionaire Elon Musk, US President Donald Trump made it clear that India will not be ...

Indian drugmakers earn a significant share of revenue from the US, the largest importer of Indian pharma products ...

The Nifty Pharma index dropped as much as 2% in early trade. Sun Pharma fell nearly 2%, Dr Reddy’s dropped as much as 4%, and ...

From Delhi's new CM announcement today to Trump's pharma tariff threat and Tesla's India plans — Here are the top 11 news ...

Indian pharma stocks faced selling pressure on February 19 after Trump announced potential tariffs on pharmaceutical imports.

After steel and aluminium, US President Donald Trump has announced targeted tariffs on automobiles, semiconductors, and ...

Indian stock markets on Wednesday opened lower despite mixed global cues and uncertainties and US tariff concerns announced ...

Stocks in the Nifty Pharma index were down by as much as 6% following US President Donald Trump's proposal to impose tariffs; ...

The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of ...